- Home
- RDY vs H Comparison
RDY vs H Comparison
Compare RDY & H Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDY
- H
- Stock Information
- Founded
- RDY 1984
- H 1957
- Country
- RDY India
- H United States
- Employees
- RDY N/A
- H N/A
- Industry
- RDY Biotechnology: Pharmaceutical Preparations
- H Hotels/Resorts
- Sector
- RDY Health Care
- H Consumer Discretionary
- Exchange
- RDY Nasdaq
- H Nasdaq
- Market Cap
- RDY 11.8B
- H 13.9B
- IPO Year
- RDY N/A
- H 2009
- Fundamental
- Price
- RDY $14.12
- H $142.97
- Analyst Decision
- RDY Strong Buy
- H Buy
- Analyst Count
- RDY 2
- H 18
- Target Price
- RDY $16.95
- H $152.11
- AVG Volume (30 Days)
- RDY 962.0K
- H 1.0M
- Earning Date
- RDY 07-23-2025
- H 10-30-2025
- Dividend Yield
- RDY 0.51%
- H 0.42%
- EPS Growth
- RDY 2.20
- H N/A
- EPS
- RDY 0.79
- H 4.36
- Revenue
- RDY $3,897,394,052.00
- H $3,218,000,000.00
- Revenue This Year
- RDY $7.33
- H $118.81
- Revenue Next Year
- RDY $1.96
- H $4.84
- P/E Ratio
- RDY $17.94
- H $32.85
- Revenue Growth
- RDY 15.86
- H N/A
- 52 Week Low
- RDY $12.26
- H $102.43
- 52 Week High
- RDY $16.41
- H $168.20
- Technical
- Relative Strength Index (RSI)
- RDY 45.65
- H 52.01
- Support Level
- RDY $14.08
- H $141.40
- Resistance Level
- RDY $14.32
- H $147.45
- Average True Range (ATR)
- RDY 0.18
- H 3.11
- MACD
- RDY 0.03
- H 0.52
- Stochastic Oscillator
- RDY 10.38
- H 61.84
About RDY Dr. Reddy's Laboratories Ltd
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
About H Hyatt Hotels Corporation
Hyatt is an operator of owned (3% of total rooms) and managed and franchised (97%) properties across about 30 upscale luxury brands, which includes vacation brands (Apple Leisure Group, Hyatt Ziva, and Hyatt Zilara), the recently launched full-service lifestyle brand Hyatt Centric, the soft lifestyle brand Unbound, the wellness brand Miraval, and the midscale extended-stay brand Studios. Hyatt acquired Two Roads Hospitality in 2018 and Apple Leisure Group in 2021. The regional exposure as a percentage of total rooms is 63% Americas, 15% rest of world, and 22% Asia-Pacific.